DAVID M MOTT Insider Trading $RYTM RHYTHM PHARMACEUTICALS, INC.
Get free email notifications about insider trading for DAVID M MOTT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID M MOTT. DAVID M MOTT is Vice Chairman and CEO in MEDIMMUNE INC /DE ($MEDI) and Director in NOVAVAX INC ($NVAX) and 10% Owner in ARCA biopharma, Inc. ($ABIO) and 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and 10% Owner in Care.com Inc ($CRCM) and Director in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and Director in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Roka BioScience, Inc. ($ROKA) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and Director in TESARO, Inc. ($TSRO) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and Director in Epizyme, Inc. ($EPZM) and Director in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and Director in IMARA Inc. ($IMRA) and 10% Owner in Elastic N.V. ($ESTC) and Director in Nightstar Therapeutics plc ($NITE) and 10% Owner in Surface Oncology, Inc. ($SURF) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM).
DAVID M MOTT in RHYTHM PHARMACEUTICALS, INC.
Trading Symbol: RYTMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 1,432,248 shares
Latest Transaction: Oct 10 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of DAVID M MOTT in RHYTHM PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, ADAP, APPN, ABIO, ARDX, AVEO, CRCM, CASC, CERC, ESTC, EPZM, GNCA, IMRA, ILIU, MEDI, MRSN, MIRM, MULE, NITE, NVAX, RARX, RGLS, RYTM, ROKA, SURF, SYBX, TSRO, TCON, TRVI
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTI ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 2,927,708 | 0 | 0 | |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTI ... | MOTT DAVID M | 10% Owner | Option Exercise | C | 0.00 | 1,402,870 | 0 | 0 | |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTI ... | MOTT DAVID M | 10% Owner | Buy | P | 17.00 | 550,000 | 9,350,000 | 4,909,956 | 4.4 M to 4.9 M (+12.61 %) |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTI ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 2,927,708 | 0 | 4,359,956 | 1.4 M to 4.4 M (+204.41 %) |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTI ... | MOTT DAVID M | 10% Owner | Buy | C | 0.00 | 1,402,870 | 0 | 1,432,248 | 29.4 K to 1.4 M (+4,775.24 %) |
Page: 1